Literature DB >> 10646883

Gene rearrangement and Chernobyl related thyroid cancers.

M Santoro1, G A Thomas, G Vecchio, G H Williams, A Fusco, G Chiappetta, V Pozcharskaya, T I Bogdanova, E P Demidchik, E D Cherstvoy, L Voscoboinik, N D Tronko, A Carss, H Bunnell, M Tonnachera, J Parma, J E Dumont, G Keller, H Höfler, E D Williams.   

Abstract

The increase in thyroid carcinoma post-Chernobyl has been largely confined to a specific subtype of papillary carcinoma (solid/follicular). This subtype is observed predominantly in children under 10 in unirradiated populations, but maintains a high frequency in those aged 10-15 from those areas exposed to fallout from the Chernobyl accident. The aim of this study was to link morphology with molecular biology. We examined 106 papillary carcinomas from children under the age of 15 at operation. All were examined for rearrangements of the RET oncogene by reverse transcription polymerase chain reaction (RT-PCR); a subset of these cases were also examined for mutations of the three ras oncogenes, exon 10 of the thyroid stimulating hormone receptor, associated more usually with a follicular rather than papillary morphology, and exons 5, 6, 7 and 8 of the p53 gene, commonly involved in undifferentiated thyroid carcinoma. Rearrangements of the REToncogene were found in 44% of papillary carcinomas in which we studied fresh material; none of the tumours examined showed mutation in any of the other genes. The two rearrangements resulting from inversion of part of chromosome 10 (PTC1 and PTC3) accounted for the majority of RET rearrangements identified, with PTC1 being associated with papillary carcinomas of the classic and diffuse sclerosing variants and PTC3 with the solid/follicular variant.

Entities:  

Mesh:

Year:  2000        PMID: 10646883      PMCID: PMC2363283          DOI: 10.1054/bjoc.1999.0921

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  40 in total

1.  Thyroid cancer after Chernobyl.

Authors:  K Baverstock; B Egloff; A Pinchera; C Ruchti; D Williams
Journal:  Nature       Date:  1992-09-03       Impact factor: 49.962

2.  Thyroid cancer after Chernobyl.

Authors:  V S Kazakov; E P Demidchik; L N Astakhova
Journal:  Nature       Date:  1992-09-03       Impact factor: 49.962

3.  Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors.

Authors:  C Challeton; A Bounacer; J A Du Villard; B Caillou; F De Vathaire; R Monier; M Schlumberger; H G Suárez
Journal:  Oncogene       Date:  1995-08-03       Impact factor: 9.867

4.  Thyroid cancer in the Ukraine.

Authors:  I A Likhtarev; B G Sobolev; I A Kairo; N D Tronko; T I Bogdanova; V A Oleinic; E V Epshtein; V Beral
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

5.  Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident.

Authors:  T Ito; T Seyama; K S Iwamoto; T Mizuno; N D Tronko; I V Komissarenko; E D Cherstovoy; Y Satow; N Takeichi; K Dohi
Journal:  Lancet       Date:  1994-07-23       Impact factor: 79.321

6.  Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

Authors:  M Santoro; F Carlomagno; I D Hay; M A Herrmann; M Grieco; R Melillo; M A Pierotti; I Bongarzone; G Della Porta; N Berger
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

7.  NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident.

Authors:  C Beimfohr; S Klugbauer; E P Demidchik; E Lengfelder; H M Rabes
Journal:  Int J Cancer       Date:  1999-03-15       Impact factor: 7.396

8.  Point mutations in the thyrotropin receptor in human thyroid tumors.

Authors:  M Ohno; T Endo; K Ohta; K Gunji; T Onaya
Journal:  Thyroid       Date:  1995-04       Impact factor: 6.568

9.  In vitro irradiation is able to cause RET oncogene rearrangement.

Authors:  T Ito; T Seyama; K S Iwamoto; T Hayashi; T Mizuno; N Tsuyama; K Dohi; N Nakamura; M Akiyama
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

10.  Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas.

Authors:  G Manenti; S Pilotti; F C Re; G Della Porta; M A Pierotti
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

View more
  19 in total

1.  Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms.

Authors:  M Ladanyi
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  Understanding the genotype of follicular thyroid tumors.

Authors:  Jennifer Hunt
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

3.  Prevention of DNA double-strand breaks induced by radioiodide-(131)I in FRTL-5 thyroid cells.

Authors:  Jerome M Hershman; Armen Okunyan; Yelena Rivina; Sophie Cannon; Victor Hogen
Journal:  Endocrinology       Date:  2010-12-29       Impact factor: 4.736

Review 4.  Differentiated thyroid cancer: focus on emerging treatments for radioactive iodine-refractory patients.

Authors:  Joshua J Gruber; A Dimitrios Colevas
Journal:  Oncologist       Date:  2015-01-23

5.  BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic.

Authors:  V Sykorova; S Dvorakova; A Ryska; J Vcelak; E Vaclavikova; J Laco; D Kodetova; R Kodet; A Cibula; J Duskova; A Hlobilkova; J Astl; D Vesely; J Betka; J Hoch; S Smutny; J Cap; P Vlcek; Z Novak; B Bendlova
Journal:  J Endocrinol Invest       Date:  2009-12-04       Impact factor: 4.256

Review 6.  Molecular pathogenesis and mechanisms of thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Nat Rev Cancer       Date:  2013-03       Impact factor: 60.716

Review 7.  Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer.

Authors:  Sujata Narayanan; A Dimitrios Colevas
Journal:  Curr Treat Options Oncol       Date:  2016-06

Review 8.  Mechanisms of chromosomal rearrangements in solid tumors: the model of papillary thyroid carcinoma.

Authors:  Manoj Gandhi; Viktoria Evdokimova; Yuri E Nikiforov
Journal:  Mol Cell Endocrinol       Date:  2009-09-18       Impact factor: 4.102

Review 9.  Update: the status of clinical trials with kinase inhibitors in thyroid cancer.

Authors:  Samuel A Wells; Massimo Santoro
Journal:  J Clin Endocrinol Metab       Date:  2014-01-13       Impact factor: 5.958

10.  Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers.

Authors:  Julio C Ricarte-Filho; Sheng Li; Maria E R Garcia-Rendueles; Cristina Montero-Conde; Francesca Voza; Jeffrey A Knauf; Adriana Heguy; Agnes Viale; Tetyana Bogdanova; Geraldine A Thomas; Christopher E Mason; James A Fagin
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.